NASDAQ:ARTC - ArthroCare Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0.30 (1.20%)
Get New ArthroCare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARTC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARTC

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for ArthroCare in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for ARTC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in ArthroCare. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/16/2020Raymond JamesInitiated CoverageOutperformN/A
1/22/2018Chardan CapitalInitiated CoverageBuyLow
(Data available from 7/23/2016 forward)
ArthroCare logo
ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare’s two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It’s Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $1.61
Low: $1.48
High: $1.76

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ArthroCare?

The following Wall Street analysts have issued reports on ArthroCare in the last year:
View the latest analyst ratings for ARTC.

What is the current price target for ArthroCare?

0 Wall Street analysts have set twelve-month price targets for ArthroCare in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ArthroCare in the next year.
View the latest price targets for ARTC.

What is the current consensus analyst rating for ArthroCare?

ArthroCare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ARTC.

What other companies compete with ArthroCare?

How do I contact ArthroCare's investor relations team?

ArthroCare's physical mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company's listed phone number is +1-512-3913900. The official website for ArthroCare is www.arthrocare.com.